Skip Navigation
Skip to contents

PHRP : Osong Public Health and Research Perspectives

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
3 "Saber Soltani"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Review Articles
Worldwide prevalence of fungal coinfections among COVID-19 patients: a comprehensive systematic review and meta-analysis
Saber Soltani, Milad Zandi, Samireh Faramarzi, Ramin Shahbahrami, Mohebat Vali, Sara Akhavan Rezayat, Reza Pakzad, Pooneh Malekifar, Iraj Pakzad, Neda Jahandoost, Jalal Moludi
Osong Public Health Res Perspect. 2022;13(1):15-23.   Published online February 8, 2022
DOI: https://doi.org/10.24171/j.phrp.2021.0293
  • 7,715 View
  • 121 Download
  • 5 Web of Science
AbstractAbstract PDFSupplementary Material
Microbial coinfections can increase the morbidity and mortality rates of viral respiratory diseases. Therefore, this study aimed to determine the pooled prevalence of fungal coinfections in coronavirus disease 2019 (COVID-19) patients. Web of Science, Medline, Scopus, and Embase were searched without language restrictions to identify the related research on COVID-19 patients with fungal coinfections from December 1, 2019, to December 30, 2020. A random-effects model was used for analysis. The sample size included 2,246 patients from 8 studies. The pooled prevalence of fungal coinfections was 12.60%. The frequency of fungal subtype coinfections was 3.71% for Aspergillus, 2.39% for Candida, and 0.39% for other. The World Health Organization’s Regional Office for Europe and Regional Office for Southeast Asia had the highest (23.28%) and lowest (4.53%) estimated prevalence of fungal coinfection, respectively. Our findings showed a high prevalence of fungal coinfections in COVID-19 cases, which is a likely contributor to mortality in COVID-19 patients. Early identification of fungal pathogens in the laboratory for COVID-19 patients can lead to timely treatment and prevention of further damage by this hidden infection.
The role of lipids in the pathophysiology of coronavirus infections
Milad Zandi, Parastoo Hosseini, Saber Soltani, Azadeh Rasooli, Mona Moghadami, Sepideh Nasimzadeh, Farzane Behnezhad
Osong Public Health Res Perspect. 2021;12(5):278-285.   Published online October 15, 2021
DOI: https://doi.org/10.24171/j.phrp.2021.0153
  • 5,828 View
  • 170 Download
  • 2 Web of Science
  • 2 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDF
Coronaviruses, which have been known to cause diseases in animals since the 1930s, utilize cellular components during their replication cycle. Lipids play important roles in viral infection, as coronaviruses target cellular lipids and lipid metabolism to modify their host cells to become an optimal environment for viral replication. Therefore, lipids can be considered as potential targets for the development of antiviral agents. This review provides an overview of the roles of cellular lipids in different stages of the life cycle of coronaviruses.

Citations

Citations to this article as recorded by  
  • PEDV inhibits HNRNPA3 expression by miR-218-5p to enhance cellular lipid accumulation and promote viral replication
    Xiaojie Shi, Qi Zhang, Naling Yang, Quanqiong Wang, Yanxia Zhang, Xingang Xu, Xiang-Jin Meng, Ying Fang
    mBio.2024;[Epub]     CrossRef
  • Orsay Virus Infection of Caenorhabditis elegans Is Modulated by Zinc and Dependent on Lipids
    Luis Alberto Casorla-Perez, Ranya Guennoun, Ciro Cubillas, Bo Peng, Kerry Kornfeld, David Wang, Rebecca Ellis Dutch
    Journal of Virology.2022;[Epub]     CrossRef
Severe acute respiratory syndrome coronavirus 2 and respiratory syncytial virus coinfection in children
Milad Zandi, Saber Soltani, Mona Fani, Samaneh Abbasi, Saeedeh Ebrahimi, Ali Ramezani
Osong Public Health Res Perspect. 2021;12(5):286-292.   Published online October 1, 2021
DOI: https://doi.org/10.24171/j.phrp.2021.0140
  • 7,011 View
  • 161 Download
  • 10 Web of Science
  • 9 Crossref
AbstractAbstract PDF
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has infected many people around the world. Children are considered an important target group for SARS-CoV-2, as well as other viral infections such as respiratory syncytial virus infection. Both SARS-CoV-2 and respiratory syncytial virus can affect the respiratory tract. Coinfection of SARS-CoV-2 and respiratory syncytial virus can pose significant challenges in terms of diagnosis and treatment in children. This review compares the symptoms, diagnostic methods, and treatment of COVID-19 and respiratory syncytial virus infection in children.

Citations

Citations to this article as recorded by  
  • Evaluating an extraction-free sample preparation method for multiplex detection of SARS-Cov-2, influenza A/B, and RSV with implementation on a microfluidic chip
    Fatemeh Ahmadi, Fatemeh Zahra Zanganeh, Iman Amani Tehrani, Saeed Shoaee, Hamzeh Choobin, Ali Bozorg, Mojtaba Taghipoor
    Diagnostic Microbiology and Infectious Disease.2024; 109(3): 116325.     CrossRef
  • Results from the second WHO external quality assessment for the molecular detection of respiratory syncytial virus, 2019–2020
    Thomas Williams, Sandra Jackson, Ian Barr, Shabana Bi, Jinal Bhiman, Joanna Ellis, Anne von Gottberg, Stephen Lindstrom, Teresa Peret, Sanjiv Rughooputh, Mariana Viegas, Siddhivinayak Hirve, Maria Zambon, Wenqing Zhang
    Influenza and Other Respiratory Viruses.2023;[Epub]     CrossRef
  • The Impact of Coronavirus Disease 2019 on Viral, Bacterial, and Fungal Respiratory Infections
    Ashley Losier, Gayatri Gupta, Mario Caldararo, Charles S. Dela Cruz
    Clinics in Chest Medicine.2023; 44(2): 407.     CrossRef
  • Viral Coinfection of Children Hospitalized with Severe Acute Respiratory Infections during COVID-19 Pandemic
    Célia Regina Malveste Ito, André Luís Elias Moreira, Paulo Alex Neves da Silva, Mônica de Oliveira Santos, Adailton Pereira dos Santos, Geovana Sôffa Rézio, Pollyanna Neta de Brito, Alana Parreira Costa Rezende, Jakeline Godinho Fonseca, Fernanda Aparecid
    Biomedicines.2023; 11(5): 1402.     CrossRef
  • Clinical Relevance of RSV and SARS-CoV-2 Coinfections in Infants and Young Children
    Rosa Rodriguez-Fernandez, Felipe González-Martínez, Jimena Perez-Moreno, María Isabel González-Sánchez, Blanca Toledo del Castillo, Irene Mingueza de la Paz, Laura Diaz Pozo, Asuncion Mejias, Octavio Ramilo
    Pediatric Infectious Disease Journal.2023; 42(12): e473.     CrossRef
  • Targeting Host Calcium Channels and Viroporins: A Promising Strategy for SARS-CoV-2 Therapy
    Mona Fani, Maryam Moossavi, Hasan Bakhshi, Abozar Nasiri Jahrodi, Mohammad Reza Khazdair, Amir Hossein Zardast, Shokouh Ghafari
    Future Virology.2023; 18(12): 797.     CrossRef
  • Respiratory syncytial virus, recurrent wheeze and asthma: A narrative review of pathophysiology, prevention and future directions
    Elly Binns, Jane Tuckerman, Paul V Licciardi, Danielle Wurzel
    Journal of Paediatrics and Child Health.2022; 58(10): 1741.     CrossRef
  • Impact of genetic polymorphisms related to innate immune response on respiratory syncytial virus infection in children
    Laura Elena Córdova-Dávalos, Alicia Hernández-Mercado, Claudia Berenice Barrón-García, Augusto Rojas-Martínez, Mariela Jiménez, Eva Salinas, Daniel Cervantes-García
    Virus Genes.2022; 58(6): 501.     CrossRef
  • Clinical and epidemiological characteristics of SARS-CoV-2 virus in ambulatory children under 2 years old
    Carolina A. Perez, Ivana Ormazabal, Javier Pérez-Valenzuela, Andrea Araya, Rafael A. Medina, Cecilia Perret
    Frontiers in Pediatrics.2022;[Epub]     CrossRef

PHRP : Osong Public Health and Research Perspectives